当前位置:首页 - 行情中心 - 创新医疗(002173) - 财务分析 - 现金流量表

创新医疗

(002173)

  

流通市值:69.02亿  总市值:72.37亿
流通股本:4.21亿   总股本:4.41亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金525,892,737.79368,028,720.69172,529,659.37832,594,822.01
  收到的税费返还160,904.29160,904.29--
  收到其他与经营活动有关的现金8,242,789.396,240,094.6114,046,606.1618,272,545.08
  经营活动现金流入小计534,296,431.47374,429,719.59186,576,265.53850,867,367.09
  购买商品、接受劳务支付的现金248,547,547.83166,149,303.2361,569,407.53365,217,232.98
  支付给职工以及为职工支付的现金253,344,241.47174,860,226.4892,897,934.23348,206,267.61
  支付的各项税费13,380,024.9510,993,314.437,544,536.3115,140,820.52
  支付其他与经营活动有关的现金33,222,429.3724,912,897.2428,066,186.1246,372,884.47
  经营活动现金流出小计548,494,243.62376,915,741.38190,078,064.19774,937,205.58
  经营活动产生的现金流量净额-14,197,812.15-2,486,021.79-3,501,798.6675,930,161.51
二、投资活动产生的现金流量:
  收回投资收到的现金186,344,611.18186,347,018.28-208,036,380.93
  处置固定资产、无形资产和其他长期资产收回的现金净额234,770.5193,129.08-96,801.84
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计186,579,381.68186,540,147.36-208,133,182.77
  购建固定资产、无形资产和其他长期资产支付的现金16,016,669.9510,097,443.415,719,340.484,519,356.31
  投资支付的现金160,899,140.2135,901,787.45,798,579.77120,100,000
  取得子公司及其他营业单位支付的现金---1,066,405.35
  投资活动现金流出小计176,915,810.15145,999,230.8111,517,920.17205,685,761.66
  投资活动产生的现金流量净额9,663,571.5340,540,916.55-11,517,920.172,447,421.11
三、筹资活动产生的现金流量:
  取得借款收到的现金45,000,00045,000,00015,000,00018,000,000
  收到其他与筹资活动有关的现金82,500-44,447.225,006,676.09
  筹资活动现金流入小计45,082,50045,000,00015,044,447.2223,006,676.09
  偿还债务支付的现金35,200,00010,000,00010,000,00015,800,000
  分配股利、利润或偿付利息支付的现金1,890,864.951,350,864.71650,552.962,590,902.29
  支付其他与筹资活动有关的现金61,018,080.5757,165,407.642,437,043.0613,705,415.65
  筹资活动现金流出小计98,108,945.5268,516,272.3513,087,596.0232,096,317.94
  筹资活动产生的现金流量净额-53,026,445.52-23,516,272.351,956,851.2-9,089,641.85
五、现金及现金等价物净增加额-57,560,686.1414,538,622.41-13,062,867.6369,287,940.77
  加:期初现金及现金等价物余额186,791,374.21186,791,374.21186,791,374.21117,503,433.44
  期末现金及现金等价物余额129,230,688.07201,329,996.62173,728,506.58186,791,374.21
补充资料:
  净利润--54,698,244.55--36,255,305.06
  资产减值准备--1,695,658.64--2,803,942.52
  固定资产和投资性房地产折旧-40,060,948.39-78,882,995.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-40,060,948.39-78,882,995.24
  无形资产摊销-4,943,025.43-7,994,895.71
  长期待摊费用摊销-3,622,350.53-7,030,892.6
  处置固定资产、无形资产和其他长期资产的损失--25,803.11--15,644.3
  固定资产报废损失-352,560.11-1,922,725.11
  公允价值变动损失--1,025,434.25--4,772,921.17
  财务费用-2,059,760.45-3,815,098.77
  投资损失--535,968.55--32,155,570.61
  递延所得税-41,014.88-6,544,924.45
  其中:递延所得税资产减少-780,021.95-7,388,647.83
    递延所得税负债增加--739,007.07--843,723.38
  存货的减少-15,717,776.37-5,934,116.66
  经营性应收项目的减少-19,064,899.45-38,997,299.14
  经营性应付项目的增加--31,506,878.43--10,814,318.95
  其他--2,898,083.99-2,536,585.32
  融资租入固定资产---12,908,562.57
  现金的期末余额-201,329,996.62-186,791,374.21
  减:现金的期初余额-186,791,374.21-117,503,433.44
  现金及现金等价物的净增加额-14,538,622.41-69,287,940.77
公告日期2026-10-232026-08-152026-04-302026-04-25
审计意见(境内)标准无保留意见
TOP↑